BioSpace News Archive

Fraser, Minnesota’s largest and most experienced provider of autism and early childhood mental health services, is now forming summer skills groups for children and young adults who need help building social interaction skills.

BioPharmX Corporation (NYSE American: BPMX), a specialty pharmaceutical company focused on developing innovative medical dermatology products, today reports financial results for the quarter ended April 30, 2019.

Baxter International Inc. (NYSE:BAX), a leading global medical products company, will host a conference call to discuss its second quarter 2019 financial results on Thursday, July 25, 2019, at 7:30 a.m. Central Time.

MiMedx Group, Inc. (OTC PINK: MDXG) (“MiMedx” or the “Company”), an industry leader in advanced wound care and an emerging therapeutic biologics company, today announced it has entered into a loan agreement with Blue Torch Finance LLC (“Blue Torch”

Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced the Company will be participating in the BMO 2019 Prescriptions for Success Healthcare Conference in New York City.

As the new cover story of Nature Biomedical Engineering, the CRISPR-Chip technology from our Innovation partner Nanosens Innovations Inc.showcases a great example of how Cardea’s graphene biosensors can be used to create innovative and first-of-a-kind life-science products.

Over the last three years the STAR4BBI project has studied policy and standardisation hurdles that bio-based industries face. During the recent stakeholders’ workshop in Cologne, a set of seven measures to achieve better policies and standards for bio-based industries had been concluded.

Polarean Imaging plc (AIM: POLX), the clinical stage medical-imaging technology company, with a proprietary drug-device combination product for the visualisation of pulmonary function in the magnetic resonance imaging (MRI) market, announces a further update regarding the Company’s Phase III Clinical Trials (the “Clinical Trials”), following the Company’s announcement of 13 May 2019.

IBA (Ion Beam Applications SA), the world’s leading provider of proton therapy solutions, is pleased to announce the first Flash irradiation in an IBA Proteus®ONE compact gantry treatment room at the Rutherford Cancer Centre Thames Valley in Reading, United Kingdom, on June 8, 2019.

Digital Science has today launched a report on the state of open access monographs. The report addresses the question of how we integrate and value monographs in the increasingly open digital scholarly network.